Genetically determined serum serine level has a novel causal effect on multiple sclerosis risk and predicts disability progression.
Xin LinYuanhao YangValery Fuh-NgwaXianyong YinSteve Simpson YapIngrid A van der MeiSimon A BroadleyAnne-Louise Ponsonbynull nullKathryn P BurdonBruce V TaylorYuan ZhouPublished in: Journal of neurology, neurosurgery, and psychiatry (2023)
These findings support investigating serine as an important candidate biomarker for MS onset and disability progression.